Kliniki Neuroradiochirurgii Sp. z o.o. — Clinical Trial Site

9 Registered trials

2 Currently recruiting

Organisation

Kliniki Neuroradiochirurgii Sp. z o.o.

Location

Radom, Poland

Identifier

ORG-100044193

Address

Ul. Uniwersytecka 6a, 26-601, Poland

Departments

Kliniczny Oddzial Chemioterapii
Kliniczny Oddział Chemioterapii
NA
Oddział Onkologii Klinicznej Radomskie Centrum Onkologii
Oncology
Radomskie Centrum Onkologii im. Bohaterów Radomskiego Czerwca '76 Kliniczny Oddział Chemioterapii
Radomskie Centrum Onkologii, Kliniczny Oddzial Radioterapii
Radomskie Centrum Onkologii, Kliniczny Oddział Chemioterapii

Clinical trials at this site (9)

Search interface

A PHASE 2 STUDY TO RESEARCH THE SAFETY AND EFFICACY OF TRASTUZUMAB DERUXTECAN VERSUS CDK4/6I PLUS ENDOCRINE THERAPY IN ADVANCED BREAST CANCE… Recruiting

2024-512360-55-00 Unresectable locally recurrent or metastatic hormone re 4 2025-06-30
A trial to learn how well saruparib with camizestrant works and how safe it is in adults with advanced breast cancer that is hormone recepto… Recruiting

2023-504180-16-00 Advanced Breast Cancer 5 2025-04-07
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients with previously treated KRAS G12C-positive… Ended

2024-510908-37-00 KRAS G12C-Positive Advanced or Metastatic Non-Small Cel 5 2024-08-28
An Open-label, Randomized Phase 3 Study of Immune and Targeted Combination Therapies, as First-line Treatment in Participants with Advanced … Ended

2022-502122-41-00 Clear cell renal cancer 5 2021-05-11
Apalutamide, Radiotherapy and LHRH Agonist in High-Risk Hormone-Sensitive Prostate Cancer Patients Assessed by PSMA-PET Ended

2023-505852-23-00 High risk recurrent prostate cancer previously treated 5 2020-11-12
A trial to learn how well durvalumab and chemotherapy with or without tremelimumab work in adults with advanced cancer of the bladder or uri… Ended

2024-510976-19-00 Patients with Unresectable Locally Advanced or Metastat 5 2018-11-30
A global study of volrustomig (MEDI5752) plus chemotherapy versus pembrolizumab plus chemotherapy for participants with metastatic non-small… Halted

2023-503298-39-00 Metastatic Non-Small Cell Lung Cancer (mNSCLC) 5 2024-06-13
Study Comparing Bemarituzumab plus Chemotherapy with Placebo and Chemotherapy in Previously Untreated Advanced Gastric or Gastroesophageal J… Ended

2023-505457-40-00 Previously Untreated Advanced Gastric or Gastroesophage 5 2022-02-02
Phase 3 Study of Pembrolizumab/Placebo plus Enzalutamide plus ADT in mHSPC Ended

2023-507024-24-00 Metastatic hormone sensitive prostate cancer 5 2020-05-05